19 June 2025
Over the past two months, we’ve had the privilege of engaging with the healthcare communications and patient engagement communities at MAPS EMEA, ISMPP Annual, ISPOR US and Patients as Partners Europe. Across continents and conversations, one theme clearly stood out: patient involvement is no longer optional – it is essential.
Oxford PharmaGenesis Commercial Director Dr Richard White was Chairman of the 16th Annual Meeting of The International Publication Planning Association (TIPPA), held in San Diego, USA on 21–22 February 2017, and provides his insights on the conference.
Teams across the Oxford PharmaGenesis offices have been celebrating Pi Day after more than 100 of us registered with ORCID, joining a community of over 3.14 million people who share the vision of transparency and trust in research and innovation.
As a leading healthcare communications company and a proud member of the Reciprocate network, Oxford PharmaGenesis takes its corporate social responsibilities very seriously.
Today, 28 February 2017, marks the 10th international Rare Disease Day and this year’s theme is ‘Research‘.
To mark World Cancer Day, we asked everyone at Oxford PharmaGenesis for their burning questions about cancer. We then asked our Oncology team to give their views on the most frequently asked questions – here is what they said.
Can the pharmaceutical industry help to advance the model for publishing of scientific research? This question has assumed greater importance as other funders have started to flex their muscles, introducing open access policies and even their own publishing platforms (e.g. Royal Society Open Science, Wellcome Open Research), but stringent regulation and widespread mistrust of open…
